Studies find faults in FDA approval process for cardiac devices

12/29/2009 | Wall Street Journal, The · NYTimes.com

The FDA approves some heart devices based on a single clinical study and other inadequate standards, according to two studies published separately in two medical journals. Dr. Jeffrey Shuren, acting director of the FDA's Center for Devices and Radiological Health, said the agency has started developing tougher standards and has called on firms to collaborate with the FDA in creating specific objectives for their clinical trials.

View Full Article in:

Wall Street Journal, The · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC